文献速递眼底病与葡萄膜炎

6-姜烯酚通过激活HIF-1α调控炎症反应与内质网应激减轻内毒素诱导性葡萄膜炎

6-Shogaol Alleviates Endotoxin-Induced Uveitis via Activation of HIF-1α to Regulate Inflammatory Responses and Endoplasmic Reticulum Stress.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

本研究建立内毒素诱导性葡萄膜炎(EIU)小鼠模型评估6-姜烯酚(6-S)的治疗作用,并通过RNA测序、网络药理学及BV2细胞实验探讨机制。结果显示6-S减轻EIU,抑制促炎细胞因子表达,下调GRP78、ATF4、CHOP并抑制PERK、IRE1α磷酸化,减轻内质网肿胀与细胞钙超载;6-S上调HIF-1α,抑制HIF-1α后其抗炎及缓解内质网应激作用基本消失。结论为6-S通过调控HIF-1α表达缓解内质网应激与炎症反应,从而改善EIU预后。

要点

  • 6-S减轻EIU小鼠眼病严重程度并抑制体内外促炎细胞因子表达。
  • 6-S下调GRP78、ATF4、CHOP,抑制PERK与IRE1α磷酸化,减轻内质网肿胀及细胞钙超载。
  • 抑制HIF-1α后6-S的抗炎与缓解内质网应激作用基本消失。

核心结论

  • 6-S通过调控HIF-1α表达缓解内质网应激与炎症反应,从而改善EIU预后。

研究设计与样本

  • 构建内毒素诱导性葡萄膜炎(EIU)小鼠模型评估6-S的治疗潜力,采用眼前节评估、临床评分与病理染色评价疾病严重程度。
  • 采用RNA测序与网络药理学探索潜在分子机制;体外以脂多糖刺激BV2细胞。
  • 检测眼球与细胞中促炎细胞因子、内质网应激标志物及HIF-1α的mRNA与蛋白水平,用透射电镜与Ca2+水平评估内质网损伤,并用HIF-1α siRNA验证6-S对HIF-1α的靶向作用。

主要发现

  • 6-S减轻小鼠EIU;RNA测序提示炎症通路是6-S治疗的潜在机制。
  • 6-S在体内和体外抑制促炎细胞因子表达;网络药理学提示其作用可能与内质网相关。
  • 6-S下调GRP78、ATF4、CHOP表达,抑制PERK与IRE1α磷酸化,减轻内质网肿胀与细胞Ca2+超载。
  • 6-S在体内和体外上调HIF-1α表达;抑制HIF-1α后6-S的抗炎及缓解内质网应激特性基本消失。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: 6-Shogaol (6-S) has demonstrated anti-inflammatory effects in various disease models; however, its effects in uveitis have not been investigated. This research intends to investigate the therapeutic mechanisms of 6-S in acute uveitis. METHODS: An endotoxin-induced uveitis (EIU) mouse model was developed to assess the therapeutic potential of 6-S for uveitis. Disease severity was evaluated through anterior segment evaluation, clinical scoring, and pathology staining. RNA sequencing (RNA-seq) and network pharmacology explored the potential molecular mechanisms. In vitro, BV2 cells were stimulated by lipopolysaccharide. The mRNA and protein levels of pro-inflammatory cytokines, endoplasmic reticulum (ER) stress markers, and hypoxia-inducible factor 1-alpha (HIF-1α) in eyeballs and cells were detected. Transmission electron microscopy and Ca2+ levels were used to evaluate ER damage. The targeting effect of 6-S on HIF-1α was tested by HIF-1α siRNA. RESULTS: 6-S alleviated EIU in mice. RNA-seq indicated that inflammatory pathways are potential mechanisms of 6-S treatment. Further results showed that 6-S inhibited the expression of pro-inflammatory cytokines in vivo and in vitro. Network pharmacology revealed that the effect of 6-S may related to the ER. 6-S downregulated GRP78, ATF4, and CHOP expression; suppressed PERK and IRE1α phosphorylation; and mitigated ER swelling and cellular Ca2+ overload. Moreover, 6-S upregulated the expression of HIF-1α in vivo and in vitro. Inhibiting HIF-1α largely eliminated the anti-inflammatory and relieving ER stress properties of 6-S. CONCLUSIONS: 6-S alleviates ER stress and inflammatory responses by modulating the expression of HIF-1α, thereby improving the prognosis of EIU.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Yi W, Wang H, Liu S, et al. 6-Shogaol Alleviates Endotoxin-Induced Uveitis via Activation of HIF-1α to Regulate Inflammatory Responses and Endoplasmic Reticulum Stress. Invest Ophthalmol Vis Sci. 2025. PMID: 40662891. doi:10.1167/iovs.66.9.43

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。